SCHEMBL7511946

SCHEMBL7511946

CC(C)(C)O[C@H]1C[C@@](n2ccc(=O)[nH]c2=O)([SiH](c2ccccc2)c2ccccc2)O[C@@H]1CON1C(=O)c2ccccc2C1=O

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7517373 0.88 RNASE1 (0.33)
SCHEMBL3577226 0.78 DUT (0.31)
SCHEMBL3567690 0.77 P2RY6 (0.35)
SCHEMBL7510541 0.76 HPGD (0.33)
SCHEMBL1335303 0.75 P2RY6 (0.30)
SCHEMBL5223432 0.74 RNASE1 (0.41)
SCHEMBL9342027 0.73 SLC28A1 (0.35)
SCHEMBL3579745 0.72 DUT (0.45)
SCHEMBL8582139 0.69 HPGD (0.31)
SCHEMBL6244002 0.65 TK1 (0.36)

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 7 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20020183502-A1 Backbone-modified oligonucleotide analogs and methods for using same MESMAEKER ALAIN DE (CH) 2002-12-05 US disclosed
EP-0586520-B1 BACKBONE MODIFIED OLIGONUCLEOTIDE ANALOGS ISIS PHARMACEUTICALS INC (US) 2000-04-19 EP disclosed
US-5602240-A MODULATE ACTIVITY OF DNA, RNA CIBA GEIGY AG. (CH) 1997-02-11 US disclosed
EP-0586520-A4 BACKBONE MODIFIED OLIGONUCLEOTIDE ANALOGS ISIS PHARMACEUTICALS INC (US) 1996-01-10 EP disclosed
US-5378825-A Backbone modified oligonucleotide analogs ISIS PHARMACEUTICALS, INC. (US) 1995-01-03 US disclosed
EP-0586520-A1 BACKBONE MODIFIED OLIGONUCLEOTIDE ANALOGS ISIS PHARMACEUTICALS, INC. (US) 1994-03-16 EP disclosed
WO-1992020823-A1 BACKBONE MODIFIED OLIGONUCLEOTIDE ANALOGS ISIS PHARMACEUTICALS, INC. (US) 1992-11-26 WO disclosed